EUVIMEDEUVIMED entdecken
Crossref

Cannabidiol as adjuvant therapy for orofacial pain in patients with temporomandibular joint disorders: a retrospective cohort pilot study

Maria Ritha Veiga Colognese, Vitoria Bortolon Jassniker, Mateus Pacer Lima, Jessily Vitoria Nunes Serra Carmo, Najib Khaled Hamaoui, Julio Katuhide Ueda, Veridiana Camilotti

Peer Review · 26.06.2026 · 8 (6) · 246-258

DOI: 10.53660/prw-2942-5285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Peer Review, online erschienen am 26.06.2026. Verfasst von Maria Ritha Veiga Colognese und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabidiol has emerged as a potential complementary therapy for chronic pain conditions, including temporomandibular disorders (TMD). This retrospective cohort pilot study evaluated the effectiveness of cannabidiol as an adjunct therapy for orofacial pain management in patients with TMD compared with conventional conservative treatment. Clinical records of 20 patients treated between November and December 2024 at a specialized center in Cascavel, Paraná, Brazil, were analyzed. Patients received either conventional treatment alone or conventional treatment combined with adjunctive cannabidiol therapy. Pain intensity was assessed using the Visual Analogue Scale (VAS) at baseline and after a four-week follow-up period. Both groups demonstrated significant reductions in pain intensity over time (p < 0.01). Patients receiving adjunctive cannabidiol therapy showed significantly lower post-treatment pain scores compared with the conventional treatment group (p < 0.05). Median VAS scores decreased from 8.00 to 3.00 in the conventional group and from 9.00 to 1.50 in the cannabidiol group. These findings suggest that cannabidiol may represent a promising complementary therapeutic strategy for reducing orofacial pain associated with temporomandibular disorders.

Zitieren

APA

Colognese, M. R. V., Jassniker, V. B., Lima, M. P., Carmo, J. V. N. S., Hamaoui, N. K., Ueda, J. K., & Camilotti, V. (2026). Cannabidiol as adjuvant therapy for orofacial pain in patients with temporomandibular joint disorders: a retrospective cohort pilot study. Peer Review, 8(6), 246-258. https://doi.org/10.53660/prw-2942-5285

Vancouver

Colognese MRV, Jassniker VB, Lima MP, Carmo JVNS, Hamaoui NK, Ueda JK, et al. Cannabidiol as adjuvant therapy for orofacial pain in patients with temporomandibular joint disorders: a retrospective cohort pilot study. Peer Review. 2026;8(6):246-258. doi:10.53660/prw-2942-5285

BibTeX
@article{Colognese2026,
  author = {Colognese, Maria Ritha Veiga and Jassniker, Vitoria Bortolon and Lima, Mateus Pacer and Carmo, Jessily Vitoria Nunes Serra and Hamaoui, Najib Khaled and Ueda, Julio Katuhide and Camilotti, Veridiana},
  title = {Cannabidiol as adjuvant therapy for orofacial pain in patients with temporomandibular joint disorders: a retrospective cohort pilot study},
  journal = {Peer Review},
  year = {2026},
  volume = {8},
  number = {6},
  pages = {246--258},
  doi = {10.53660/prw-2942-5285}
}
Kostenlos starten →